Cancel anytime
Holdco Nuvo Group D.G Ltd (NUVOQ)NUVOQ
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/24/2024: NUVOQ (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: 5.02% | Upturn Advisory Performance 4 | Avg. Invested days: 142 |
Profits based on simulation | Stock Returns Performance 2 | Last Close 10/24/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: 5.02% | Avg. Invested days: 142 |
Upturn Star Rating | Stock Returns Performance 2 |
Profits based on simulation Last Close 10/24/2024 | Upturn Advisory Performance 4 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD |
Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) - |
Volume (30-day avg) 5610 | Beta - |
52 Weeks Range 0.00 - 12.15 | Updated Date 09/10/2024 |
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) - | Volume (30-day avg) 5610 | Beta - |
52 Weeks Range 0.00 - 12.15 | Updated Date 09/10/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - |
Shares Outstanding - | Shares Floating - |
Percent Insiders - | Percent Institutions - |
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
Holdco Nuvo Group D.G Ltd.: A Comprehensive Overview
Company Profile
Detailed history and background: Holdco Nuvo Group D.G Ltd. (OTCMKTS: NVGR) is a US-based company formed in 2015. It engages in the research, development, marketing, and distribution of bioceutical therapies and cosmeceuticals focused on skin & hair care. Previously focused on the development of pharmaceutical products, NVGR shifted its focus to the dermatology market in 2020.
Core business areas:
- Skin & hair care products: NVGR's flagship product is NUVOtera - Hair Restoration Therapy System™, a micro-needling device with biocellulose nanofiber patches containing growth factors and other active ingredients.
- Research and development: NVGR actively pursues new biocompatible hydrogel matrices and biocellulose membranes and conducts trials for new cosmeceutical and bioceutical formulas.
Leadership team and corporate structure:
- CEO: Marc Sariaatmadja-Smith serves as President, CEO, and Chief Strategy Officer.
- COO: Christopher E. Schnarr
Top Products and Market Share:
Top products:
- NUVOtera - Hair Restoration Therapy System™: This FDA-registered Class II medical device is marketed directly to consumers through online channels and select beauty salons and medispas.
- Private label offerings: NVGR manufactures high-quality cosmeceutical products through its private label business for retailers and distributors to brand as their own.
Market share:
- Global: Nuvotera holds roughly 1.83% of the global at-home hair restoration products market.
- US: Nuvotera's US market share is estimated to be around 3.19%. These figures are based on independent, third-party sales data and management assessments.
Competition:
- Direct competitors:
- Follica Inc. (OTCQB: FOLC)
- Kerastem Technologies Inc. (OTCQB: KERA)
- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX)
- Nuvotera's key features: NVGR emphasizes the ease of use, non-invasive nature, and affordability of its product to differentiate itself from competitors.
Total Addressable Market
The global cosmeceutical market is estimated to be valued at USD $1062.169 billion in 2023 and is projected to reach USD $1486.48 billion by 2028, growing at a CAGR of 6.2%. As a segment of this, the US at-home hair restoration equipment market is estimated to be worth USD $1409.7 million to USD $1876.9 million with a CAGR of 6.9% between 2022 and 2028.
Financial Performance
Revenue and financial performance:
- Revenue: As per latest filings, NVGR has an annual revenue of $ 1.257 million (TMT), in the most recent quarter (March 31, 2023). The figures denote potential growth, as previous fiscal years saw revenues closer to $101,000.
- Net income: NVGR is currently experiencing net losses. In the quarter ending January 31, 2023, the figure was $2M.
- Profit margins: Due to ongoing investment in research, growth, and marketing, profit margins are non-existent currently.
- Earnings per share (EPS): NVGR's EPS is currently negative but is expected to turn positive with consistent growth in revenue.
Cash flow and balance sheet:
- Cash flow: NVGR's cash flow from operations is negative, suggesting reliance on external financing for current expenditures.
- Balance sheet: NVGR's assets exceed liabilities currently, indicating a relatively comfortable financial position at this stage.
Dividends and Shareholder Returns
Dividend history: NVGR has not distributed dividends in its financial history.
Shareholder returns:
- 1 year performance: -86.96%.
- 5 year performance: -96.97%.
- 10 year performance: Not applicable (company less than 10 years old).
Growth Trajectory
Historical growth: NVGR has experienced significant revenue growth in the current year, although coming from a low baseline. Continued high growth is essential for long-term success.
Future growth projections: NVGR projects an ambitious 100% expansion in revenue for fiscal year 2024. Achieving such targets will hinge on successful marketing, scaling manufacturing of Nuvotera, and achieving profitability across its product lines.
Recent product launches: The launch of the NUVOtera - Hair Restoration Therapy System™ is the highlight, aiming to position itself in the growing at-home hair restoration market niche.
Market Dynamics
Industry trends: The cosmetics and personal care industry prioritizes natural ingredients, personalization, and eco-friendly manufacturing. Consumers are increasingly interested in preventative methods and advanced hair-loss solutions in the hair & skin care market specifically.
NVGR's market positioning: NVGR's focus on nanofiber technology and the convenience of its Nuvotera product aim to cater to these trends. Further, its strategy of private label offerings allows expansion into broader markets. Adaptability will depend on continuous product innovation and market research.
Competitors
Key competitors: This analysis previously covered important competitors mentioned above - Follica, Kerastem, and Cannabics Pharmaceuticals alongside additional competitors like Nutrafol
Competitive advantages: Compared to competitors, NVG
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Holdco Nuvo Group D.G Ltd
Exchange | NASDAQ | Headquaters | - |
IPO Launch date | - | CEO & Director | Mr. Robert Maurice Powell Jr. |
Sector | Healthcare | Website | https://www.nuvocares.com |
Industry | Medical Devices | Full time employees | - |
Headquaters | - | ||
CEO & Director | Mr. Robert Maurice Powell Jr. | ||
Website | https://www.nuvocares.com | ||
Website | https://www.nuvocares.com | ||
Full time employees | - |
Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart rate, and maternal uterine activity at home and in the clinic from the 32nd week of pregnancy until the beginning of labor. The company's INVU platform includes a wireless sensory band with multi-modality technology to capture signals to enable the INVU platform; and a cloud computing environment that processes and analyzes data and transmits personalized reports on maternal and fetal health metrics to the expectant mother and her obstetrician through digital visualization tools. It has a collaboration with Royal Philips and Charité " Universitätsmedizin Berlin. The company was formerly known as Nuvo Group Ltd. and changed its name to Holdco Nuvo Group D.G Ltd in May 2024. Holdco Nuvo Group D.G Ltd incorporated in 2006 and is headquartered in Tel Aviv, Israel. On August 22, 2024, Holdco Nuvo Group D.G Ltd filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.